Remove 2027 Remove Communication Remove Compounding Remove Download
article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

Examples include platforms as small as autonomous units placed within a facility and mobile production trailers for compounding to platforms as large as a prefabricated, self-contained GMP facility. www.fda.gov/media/162157/download 7 Okwudire, C. Nature Communications 12, no. Discussion paper. October 2022. Madhyastha.

article thumbnail

High biologics demand spurs need for greater contract manufacturing

Pharmaceutical Technology

Meanwhile, the Indian biologics market is expected to grow to $12 billion by 2025, with a compound annual growth rate (CAGR) of 22%. GlobalData forecasts Biologics to significantly overtake sales of small molecules by $120 billion by 2027. Free Whitepaper Choosing the ‘right’ CRO/CDMO in Biopharma: What has changed?

article thumbnail

Empress Therapeutics emerges with $50m to fund small molecule development

Pharmaceutical Technology

Dr. Doug Cole, co-founder of Empress Therapeutics, explained that Chemilogics links gene pathways to small molecule compounds, allowing for drugs with the versatility of small molecules without the unpredictable, expensive, and time-consuming discovery process. Please check your email to download the Report.